Effects of an alpha2 antagonist ina 20-year-old Java monkey with MPTP-induced parkinsonian signs

Brain Research Bulletin

Volumn 26, Issue 4, 1991, Pages 627-631

  Colpaert, F C ^a   Degryse, A D ^a   Van Craenendonck, H ^a  

^a Department of Psychopharmacology Janssen Pharmaceutica B 2340 Beerse Belgium ^*

Author keywords

Alpha2 receptors; Locus coeruleus; Monkey; MPTP; Noradrenaline; Parkinson's disease; Progression

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ALPHA 2 ADRENERGIC RECEPTOR; N [1 [(2,3 DIHYDRO 1,4 BENZODIOXIN 2 YL)METHYL] 4 PIPERIDYLMETHYL] 2 BENZOTHIAZOLAMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; LOCUS CERULEUS; MONKEY; NONHUMAN; NORADRENERGIC SYSTEM; PARKINSON DISEASE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ADRENERGIC ALPHA-ANTAGONISTS; ANIMAL; BLINKING; LOCUS COERULEUS; MACACA FASCICULARIS; NEURONS; PARKINSON DISEASE, SECONDARY; PIPERIDINES; THIAZOLES; TREMOR;

EID: 0025804278     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/0361-9230(91)90106-T     Document Type: Article

References (38)

1. Norepinephrine-dopamine interactions and behavior
2. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by n-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
3. Neurochemical and electrophysiological evidence for a projection from the locus coeruleus to the substantia nigra
4. Pharmacological characteristics of tremor, rigidity and hypokinesia induced by reserpine in rat
5. Observations following the administration of R 47243 and R 62651 to a 20 year old Java monkey with parkinsonian symptoms induced by MPTP
6. In vivo pharmacological activity of R 47243 in rat: a comparison with putative alpha 2-adrenoceptor antagonists
7. Symptoms and behavioral features induced by l-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in an old Java monkey [Macaca cynomolgus fascicularis (Raffles)]
8. Evidence that locus coeruleus is the site where clonidine and drugs acting at alpha 1- and alpha 2-adrenoceptors affect sleep and arousal mechanisms
9. α1 and α2 adrenoceptor antagonists differentially influence locomotor and stereotyped behaviour induced by d-amphetamine and apomorphine in the rat
10. The relative importance of dopamine and noradrenalinereceptor stimulation for the restoration of motor activity in reserpine or α-methyl-p-tyrosine pretreated mice
11. The involvement of noradrenaline in motor activity, as shown by rotational behaviour after unilateral lesions of the locus coeruleus
12. Variability and functional recovery in the n-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinsonism in monkeys
13. Clinical effectiveness of reserpine
14. Effects of clonidine, piperoxane and locus coeruleus lesion on the serotonergic and dopaminergic systems in raphe and caudate nucleus
15. Some aspects of the effects of acute reserpine treatment on behaviour
16. Clonidine regularizes substantia nigra dopamine cell firing
17. Natural history of the untreated pre-levodopa disease
18. The neurotoxicity of l-methyl-4-phenyl-1,2,3,6-tetradropyridine (MPTP) and its relevance to Parkinson's disease
19. Use of reserpine in a neuropsychiatric hospital
20. Behavioral effects of neuroleptics, apomorphine and amphetamine after bilateral lesions of locus coeruleus in rats
21. Evidence for existence of two opposite noradrenergic brain systems controlling behavior
22. MPTP neurotoxicity: an overview and characterization of phases of toxicity
23. Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the squirrel monkey
24. Pargyline prevents MPTP-induced parkinsonism in primates
25. Assessment of Parkinson's disease
26. The effects of locus coeruleus lesions on dopamine release in rat nucleus accumbens and caudate nucleus as determined by intracerebral dialysis
27. The effects of locus coeruleus lesions on behaviours induced by putative D1 and D2 receptor agonists
28. Relative potencies of alpha-1 and alpha-2 antagonists in the locus coeruleus, dorsal raphe and dorsal lateral geniculate nuclei: an electrophysiological study
29. Effects of locus coeruleus lesions on parkinsonian signs striatal dopamine and substantia nigra cell loss after MPTP in monkeys a possible role for the locus coeruleus in the progression of Parkinson's disease
30. Reserpine rigidity and adrenergic neurones
31. The MPTP-treated monkey: an animal model of Parkinson's disease
32. Circling behavior produced by unilateral lesions in the region of the locus coeruleus in rats
33. Catecholamine metabolism in the rat locus coeruleus as studied by in vivo differential pulse voltammetry. III. Evidence of the existence of an alpha 2-adrenergic tonic inhibition in behaving rats
34. Antiparkinsonian efficacy of a novel transdermal delivery system for (+)-PHNO MPTP-treated squirrel monkey
35. Prevention of reserpine rigidity by alpha-2 adrenergic antagonists
36. Functional and structural observations on chronically reserpinized monkeys
37. Noradrenergic alpha 1 and alpha 2 receptors: light microscopic autoradiographic localization